Tag Archives: Warren Woessner

PERSONALIZED MEDICINE TAKES OFF WHILE DIAGNOSTIC ASSAYS ARE GROUNDED

A front-page article yesterday in the New York Times and other major newspapers reminded me that drug development and methods of medical treatment will be driven by the genomics of increasingly sub-divided patient populations. As reported by GenomeWeb, summarizing an … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

1st Media, LLC v. Electronic Arts, Inc. – Specific Intent Means Specific Intent

On September 13th, the Fed. Cir. reversed a district court ruling that the inventor and the attorney who prosecuted a chain of applications claimed multi-media entertainment systems had committed inequitable conduct by failing to disclose three “relevant” references at various … Continue reading

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , | Leave a comment

Akami/McKesson Decision Re-defines Induced Infringement

In a 6-5 decision, the Fed. Cir., sitting en banc, decided two appeals which presented questions closely related to when an actor is liable for inducing infringement under 271(b); Akami Technologies, Inc. v. Limelight Networks, Inc. and McKesson Tech’s., Inc. … Continue reading

Posted in Infringement | Tagged , , , , , , , , , | Leave a comment

AUTM Eastern Regional Meeting Panel to Address Patentability Challenges

Warren Woessner will be joined by two other well-known patent attorneys,  Rodney Sparks of the University of Virginia Patent Foundation and Hans Sauer of BIO, in Philadelphia on September 13th. The panel will try to update the status of the major … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , | Leave a comment